A Prospective Trial of Virtual Home Rehabilitation After Burn Injury

December 5, 2024 updated by: Tam Pham, University of Washington

Virtual-Environment Home Rehabilitation: a Randomized Controlled Trial

The overarching goal for this prospective randomized controlled trial (PRCT) is to determine whether a virtual-environment, home-rehabilitation program improves functional outcomes for individuals after a burn injury. Specifically, this study will test the efficacy of a technology-assisted rehabilitation program against current standard of home therapy.

Study Overview

Detailed Description

This is a prospective, randomized controlled trial (PRCT) involving 50 adult burn survivors. This study tests the efficacy of a technology-assisted rehabilitation program against current standard of home therapy. There are two study groups for which subjects will be randomized: control and experimental.The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge. The experimental group receives treatment as usual, in addition to training and use of the Jintronix platform for 3 months after hospital discharge. Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98104
        • Harborview Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age greater than or equal to 18 years old (no upper age limit)
  • Ability to provide written, informed consent for study participation
  • Ability to read and understand English
  • Anticipated discharge to home environment
  • Home environment includes access to:

    • television (larger than 20 inches in diameter with High Definition Multimedia Interface input (HDMI)
    • internet and email address
    • telephone (cell phone or landline)

Exclusion Criteria:

  • Age less than 18 years
  • Inability to provide written, informed consent for study participation
  • Inability to read or understand English
  • Delirium (as determined by the Delirium Observation Score test)
  • Near-fall event at time of screening
  • Pregnant women
  • Discharge to non-home environment (e.g., shelter, street, skilled nursing facility)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: technology-assisted rehabilitation
The experimental group will receive treatment as usual, in addition to training with the Jintronix platform. Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.
The Jintronix software platform, coupled with the Microsoft Kinect for movement capture, contains individualized exercise modules to increase ROM, endurance and strength. Within this PRCT, online monitoring of activity and actigraphy measurements through a wearable device and completion of an online diary will provide enhanced monitoring of home activities.
Active Comparator: Usual care
The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge. Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.
The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of physical activity
Time Frame: 3 months after study enrollment
level of activity among enrolled subjects by actigraphy
3 months after study enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion (ROM)
Time Frame: Study enrollment, 3, 6 and 12 months after enrollment
ROM by subjects in each group
Study enrollment, 3, 6 and 12 months after enrollment
Patient-reported outcome measures (PROMIS): sleep
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
Sleep and sleep disturbance Short Form (SF)8B PROMIS tool
Study enrollment, 3, 6, 12 months after enrollment
Patient-reported outcome measures (PROMIS): social participation
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
Participation in social roles and activities PROMIS tool SF6A
Study enrollment, 3, 6, 12 months after enrollment
Patient-reported outcome measures (PROMIS): pain interference
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
Pain interference PROMIS tool SF6A
Study enrollment, 3, 6, 12 months after enrollment
Patient-reported outcome measures (PROMIS): fatigue
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
Fatigue PROMIS tool SF6A
Study enrollment, 3, 6, 12 months after enrollment
Patient-reported outcome measures (PROMIS): stiffness
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
Stiffness impact Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-ME) V2.0
Study enrollment, 3, 6, 12 months after enrollment
Patient-reported outcome measures (PROMIS): mobility
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
Mobility PROMIS tool
Study enrollment, 3, 6, 12 months after enrollment
Patient-reported outcome measures (PROMIS): upper extremity
Time Frame: Study enrollment, 3, 6, 12 months after enrollment
Upper extremity PROMIS SF7A
Study enrollment, 3, 6, 12 months after enrollment
Return to work/school
Time Frame: up to 1 year
Date when subject returns to work or school
up to 1 year
Patient reported level of activity difficulty
Time Frame: Weekly beginning 1 week after study enrollment and concluding 3 months after study enrollment
Using 1-5 difficulty scale (1=no difficulty and 5=very difficult), subject is asked how difficult his/her activity has been for the past 2 days
Weekly beginning 1 week after study enrollment and concluding 3 months after study enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tam Pham, MD, University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 8, 2018

Primary Completion (Actual)

September 30, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

March 1, 2018

First Submitted That Met QC Criteria

March 22, 2018

First Posted (Actual)

March 23, 2018

Study Record Updates

Last Update Posted (Actual)

December 11, 2024

Last Update Submitted That Met QC Criteria

December 5, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00003707

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burn Scar

Clinical Trials on Technology-assisted rehabilitation

Subscribe